Lighting device and system for reducing blood sugar by light
The light-based blood sugar-lowering illumination device utilizes a combination of red and white LEDs to activate retinal ganglion cells, influencing blood sugar metabolism. This solves the problems of difficulty in controlling blood sugar and drug side effects in existing technologies, achieving convenient blood sugar control.
Patent Information
- Application Number
- CN202411362055.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-27
- Publication Date
- 2024-11-26
AI Technical Summary
Existing technologies for blood sugar control are difficult to implement with non-pharmacological methods, while pharmacological methods may have side effects or contraindications, and there is a lack of convenient and easy-to-use blood sugar control devices.
A light-based blood glucose-lowering illumination device is provided, which combines red LEDs and white LEDs. By adjusting the current output parameters of the power module, different light emission modes can be achieved, including emitting only red light, emitting only white light, or emitting both red and white light simultaneously. This activates photosensitive retinal ganglion cells (ipRGCs), affects the neural circuits of the hypothalamus and medulla oblongata, and acts on peripheral brown adipose tissue, thereby affecting blood glucose metabolism.
While providing illumination, it lowers blood sugar levels using specific wavelengths of light. This is easy to implement, avoids the side effects of medication for blood sugar control, meets lighting needs, improves human visual perception, and lowers the user's blood sugar.
Smart Images

Figure CN119031534A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the field of new energy lighting, and in particular to a lighting device and system for photoreducing blood sugar. Background Art
[0002] Hyperglycemia refers to the level of glucose (blood sugar) in the blood being higher than the normal range. Long-term high blood sugar levels can have adverse effects on the human cardiovascular system, nervous system, kidneys, eyes, etc., increasing the risk of disease.
[0003] Existing technologies mainly control blood sugar through non-drug means such as diet control and exercise weight loss, as well as drug means such as oral hypoglycemic drugs and insulin injections. However, non-drug means such as diet control and exercise weight loss are difficult to implement. For some people, it may be difficult to adhere to a strict diet plan or exercise plan. After losing weight quickly in a short period of time, if there is no sustained healthy lifestyle, the weight may rebound. Drug means may have side effects or contraindications, and different drugs may have different side effects, such as gastrointestinal discomfort, diarrhea, nausea, etc.
[0004] Therefore, it is necessary to provide a convenient and easy-to-use sugar control device. Summary of the invention
[0005] The purpose of the present invention is to overcome the problem that existing non-drug sugar control methods such as diet control and exercise weight loss are difficult to implement, and drug sugar control methods may have side effects or contraindications, and to provide a lighting device and system for lowering blood sugar by light.
[0006] In a first aspect, the present invention provides a lighting device for photoreduction of blood sugar. The lighting device for photoreduction of blood sugar comprises: a lighting source for emitting lighting light. The lighting source comprises at least a red light LED and a white light LED. The light emission wavelength of the red light LED is 600nm to 720nm. A power module for supplying power to the lighting source. The power module is provided with two power outputs, the first power output is connected to the red light LED, and the second power output is connected to the white light LED. A processing unit is used to adjust the light emission mode of the lighting source. The processing unit adjusts the light emission mode of the lighting source by controlling the current output parameters of the power module.
[0007] According to a preferred embodiment, the light emitting modes of the lighting light source include: a first light emitting mode, in which the red light LED in the lighting light source does not emit light, and the white light LED emits light; a second light emitting mode, in which the red light LED in the lighting light source emits light, and the white light LED does not emit light; a third light emitting mode, in which the red light LED in the lighting light source emits light, and the white light LED emits light.
[0008] According to a preferred embodiment, the processing unit controls the first power supply output of the power module to be turned off and the second power supply output to be turned on, and the lighting source enters the first light-emitting mode. The processing unit controls the first power supply output of the power module to be turned on and the second power supply output to be turned off, and the lighting source enters the second light-emitting mode. The processing unit controls the first power supply output of the power module to be turned on and the second power supply output to be turned on, and the lighting source enters the third light-emitting mode.
[0009] According to a preferred embodiment, in the second light emitting mode, the radiation intensity of the red light perceived by human eyes is less than a preset radiation intensity. Preferably, the preset radiation intensity is 700 mW.
[0010] According to a preferred embodiment, in the third light emitting mode, the red light power intensity of the illumination light source is greater than the blue light power intensity. The red light power intensity = the light power intensity of the red light LED + the light power intensity of the red light in the white light LED, and the blue light power intensity = the light power intensity of the blue light in the white light LED.
[0011] According to a preferred implementation, in the third light emitting mode, the ratio of the lighting power of the red light LED to the lighting power of the white light LED is greater than or equal to 30%.
[0012] According to a preferred implementation, in the third light emitting mode, the illuminance of the red light LED is greater than the illuminance of the white light LED.
[0013] According to a preferred implementation, in the third light emitting mode, the illuminance of the red LED is greater than a second preset illuminance, wherein the preset illuminance is greater than or equal to 1000 lx.
[0014] According to a preferred embodiment, the light emission wavelength of the red light LED is at least one wavelength between 620 nm and 720 nm.
[0015] According to a preferred implementation, the red light LED is a broad-spectrum light-emitting LED, and its spectrum covers a range of 600nm to 710nm.
[0016] The present invention also provides a desk lamp for photoreducing blood sugar. The desk lamp includes: a lighting board, a power module and a processing unit. The lighting board is used to emit lighting light. A plurality of LEDs are arranged on one side surface of the lighting board. The LEDs include red light LEDs and white light LEDs. The light emission wavelength of the red light LED is 600nm to 720nm. The power module is used to supply power to the plurality of LEDs arranged on the lighting board. The processing unit is used to adjust the light emission mode of the lighting board by controlling the current output parameters of the power module.
[0017] The present invention also provides a ceiling lamp for photoreducing blood sugar. The ceiling lamp includes: an illumination light source, a power module and a processing unit. The illumination light source is used to emit illumination light. The illumination light source includes at least a red light LED and a white light LED. The light emission wavelength of the red light LED is 600nm to 720nm. The power module is used to supply power to the illumination light source. The power module is configured with two power supply outputs, the first power supply output is connected to the red light LED, and the second power supply output is connected to the white light LED. The processing unit is used to adjust the light emission mode of the illumination light source. The processing unit adjusts the light emission mode of the illumination light source by controlling the current output parameters of the power module.
[0018] The present invention also provides a floor lamp for photoreducing blood sugar. The floor lamp includes: an illumination light source, a power module and a processing unit. The illumination light source is used to emit illumination light. The illumination light source is provided with a plurality of LEDs, and the illumination light source is connected to a support. The LEDs include red light LEDs and white light LEDs. The light emission wavelength of the red light LED is 600nm to 720nm. The power module is used to supply power to the plurality of LEDs provided in the illumination light source. The processing unit is used to adjust the light emission mode of the illumination light source by controlling the current output parameters of the power module.
[0019] The present invention also provides a lighting system for photoreducing blood sugar, comprising the lighting device and a control device provided by the present invention. The control device is used to switch the lighting mode of the lighting device. The continuous lighting time of the red light LED does not exceed 30 minutes.
[0020] The present invention also provides a method for using a lighting system for photoreducing blood sugar. The lighting system is the lighting system provided by the present invention. The method for using at least comprises:
[0021] The lighting mode of the lighting device is switched by using a control device; wherein the continuous lighting time of the red light LED is set to 30 minutes;
[0022] When the lighting device continues to emit light in the second light-emitting mode for 30 minutes, the lighting device switches from the second light-emitting mode to the first light-emitting mode;
[0023] When the lighting device continues to emit light in the third light-emitting mode for 30 minutes, the lighting device switches from the third light-emitting mode to the first light-emitting mode.
[0024] Compared with the prior art, the present invention has the following beneficial effects:
[0025] The light-lowering blood sugar lighting device provided by the present invention is provided with a red light LED and a white light LED at the same time, and can emit only red light, only white light, or both red light and white light during illumination, which can meet the illumination demand and reduce the blood sugar of the user. The light-lowering blood sugar device of the present invention can illuminate the human eye with red light while realizing illumination through different light-emitting schemes, thereby reducing the blood sugar of the user. When using the present invention to reduce blood sugar, the user only needs to visually look at the light source or work and live in an environment illuminated by the present invention, which is easy to implement. BRIEF DESCRIPTION OF THE DRAWINGS
[0026] Figure 1 A schematic diagram of the structure of the lighting device for photoreducing blood sugar provided by the present invention;
[0027] Figure 2 A schematic diagram of the light-lowering blood sugar lighting device provided by the present invention using a single-wavelength red light LED for lighting;
[0028] Figure 3 A schematic diagram of the illumination device for light-lowering blood sugar provided by the present invention using a wide-band red light LED for illumination;
[0029] Figure 4 A schematic diagram of a light-assisted blood sugar-lowering desk lamp provided by the present invention;
[0030] Figure 5 A schematic diagram of a lighting panel of a light-reducing blood sugar desk lamp provided by the present invention;
[0031] Figure 6 A schematic diagram of a ceiling lamp for photoreducing blood sugar provided by the present invention;
[0032] Figure 7 The invention provides a floor lamp for lowering blood sugar by light.
[0033] Reference numerals: 110 - lighting source, 111 - lighting board, 112 - LED, 113 - support, 120 - power module, 130 - processing unit. DETAILED DESCRIPTION
[0034] The present invention is further described in detail below in conjunction with specific embodiments. However, this should not be understood as the scope of the above subject matter of the present invention being limited to the following embodiments, and all technologies realized based on the content of the present invention belong to the scope of the present invention.
[0035] Unless otherwise specified, in the description of the specific embodiments of the present invention, the terms indicating the orientation or position relationship such as "up", "down", "left", "right", "center", "inside", "outside", etc. are all based on the expression of the orientation or position relationship shown in the drawings, or are the orientation or position relationship when the invented product / equipment / device is usually used. These terms of orientation or position relationship are only for the convenience of describing the scheme of the present invention or simplifying the description in the specific embodiments, so as to facilitate the technicians to quickly understand the scheme, and do not indicate or imply that a specific device / component / element must have a specific orientation, or be constructed and operated in a specific position relationship, and therefore cannot be understood as a limitation on the present invention.
[0036] In addition, if the terms "horizontal", "vertical", "overhanging", "parallel" and the like appear, it does not mean that the corresponding devices / components / elements are required to be absolutely horizontal or vertical or overhanging or parallel, but may be slightly tilted or have deviations. For example, "horizontal" only means that its direction is more horizontal than "vertical", and does not mean that the structure must be completely horizontal, but may be slightly tilted. Alternatively, it can be simplified to mean that the corresponding devices / components / elements are set in directions such as "horizontal", "vertical", "overhanging", "parallel", etc., and can have an error / deviation of ±10% relative to the corresponding direction setting, more preferably an error / deviation within ±8%, more preferably an error / deviation within ±6%, more preferably an error / deviation within ±5%, and more preferably an error / deviation within ±4%. As long as the corresponding device / component / element is within the error / deviation range, it can still achieve its role in the scheme of the present invention.
[0037] In addition, the expressions “first”, “second”, “third”, etc., which appear in the terms, are merely used to distinguish the description of the same or similar components and should not be understood as emphasizing or implying the relative importance of specific components.
[0038] In addition, in the description of the embodiments of the present invention, "several", "plurality" and "a number" represent at least 2. It can be any number such as 2, 3, 4, 5, 6, 7, 8, 9, and even more than 9.
[0039] In addition, in the description of the technical solution of the present invention, unless otherwise clearly specified / defined / restricted, the terms "set", "install", "connect", "connected", "provided with", "laid", and "arranged" should be understood in a broad sense, for example, it can be a fixed connection, a detachable connection, or an integral connection, and can be welding, riveting, bolting, threading, and other commonly used connection means in the field. This connection can be a mechanical connection, an electrical connection, or a communication connection; it can be a direct connection, or an indirect connection through an intermediate medium, and it can be the internal connection of two elements.
[0040] Example 1
[0041] This embodiment provides a lighting device for reducing blood sugar by light. Figure 1 , a lighting device for lowering blood sugar by light, comprising: a lighting light source 110, for emitting lighting light. The lighting light source 110 comprises at least a red light LED and a white light LED. The light emission wavelength of the red light LED is 600nm to 720nm. A power supply module 120, for supplying power to the lighting light source 110. The power supply module 120 is configured with two power supply outputs, the first power supply output is connected to the red light LED, and the second power supply output is connected to the white light LED. A processing unit 130, for adjusting the light emission mode of the lighting light source 110. The processing unit 130 adjusts the light emission mode of the lighting light source 110 by controlling the current output parameters of the power supply module 120.
[0042] The light-induced blood sugar-lowering lighting device provided in this embodiment is provided with both red light LED and white light LED, and can emit only red light, only white light, or both red light and white light during illumination, which can not only meet the illumination requirements, but also improve the visual perception of the human eye. The light-induced blood sugar-lowering device can illuminate the human eye with red light while realizing illumination through different light-emitting schemes, thereby lowering the user's blood sugar. When using the present invention to lower blood sugar, the user only needs to visually look at the light source or work and live in an environment illuminated by the present invention, which is easy to implement.
[0043] When emitting red light and white light at the same time, the light-lowering blood sugar lighting device provided in this embodiment increases the proportion of red light in the lighting light perceived by the human eye by emitting red light, thereby reducing the proportion of blue light in the lighting light perceived by the human eye, achieving an anti-blue light effect and improving the visual perception of the human eye. However, the human eye can still perceive blue light, thereby avoiding drowsiness or lack of energy due to lack of blue light.
[0044] The principle by which the lighting device provided in this embodiment can lower blood sugar is that light waves of a specific wavelength enter from the visual window, directly activate photosensitive retinal ganglion cells ipRGCs (special photoreceptor cells), transmit signals through the optic nerve to a series of nerve nuclei in the hypothalamus and medulla oblongata, and finally act on the peripheral brown adipose tissue BAT through the sympathetic nerves, thereby affecting the metabolic capacity of blood sugar.
[0045] Example 2
[0046] This embodiment is a further improvement of Embodiment 1, and the repeated contents are not repeated. Preferably, the light emitting modes of the illumination light source 110 include: a first light emitting mode, in which the red light LED in the illumination light source 110 does not emit light, and the white light LED emits light; a second light emitting mode, in which the red light LED in the illumination light source 110 emits light, and the white light LED does not emit light; a third light emitting mode, in which the red light LED in the illumination light source 110 emits light, and the white light LED emits light.
[0047] Preferably, the processing unit 130 controls the first power output of the power module 120 to be turned off and the second power output to be turned on, and the lighting source 110 enters the first light-emitting mode. The processing unit 130 controls the first power output of the power module 120 to be turned on and the second power output to be turned off, and the lighting source 110 enters the second light-emitting mode. The processing unit 130 controls the first power output of the power module 120 to be turned on and the second power output to be turned on, and the lighting source 110 enters the third light-emitting mode.
[0048] Preferably, in the second light-emitting mode, the radiation intensity of the red light perceived by the human eye is less than a preset radiation intensity; wherein the preset radiation intensity is 700 mW.
[0049] Preferably, in the third light emitting mode, the red light power intensity of the illumination light source 110 is greater than the blue light power intensity. Red light power intensity = red light LED power intensity + red light power intensity in white light LED, blue light power intensity = blue light power intensity in white light LED.
[0050] Preferably, in the third light emitting mode, the ratio of the lighting power of the red light LED to that of the white light LED is greater than or equal to 30%.
[0051] Preferably, in the third light emitting mode, the illuminance of the red light LED is greater than the illuminance of the white light LED.
[0052] Preferably, in the third light emitting mode, the illuminance of the red light LED is greater than a second preset illuminance, wherein the preset illuminance is greater than or equal to 1000 lx.
[0053] Preferably, the light emission wavelength of the red light LED is at least one wavelength between 620 nm and 720 nm.
[0054] Preferably, the red light LED is a broad-spectrum light-emitting LED, and its spectrum covers a range of 600 nm to 710 nm.
[0055] Example 3
[0056] This embodiment is a further improvement on embodiment 2. Figure 2 The red light LED used in the illumination device for photoreducing blood sugar in this embodiment can emit red light of at least one wavelength in the 620nm to 720nm band. Preferably, the emission wavelength of the red light LED can also be 620nm, 655nm and 710nm. Preferably, the red light LED in this embodiment emits light of a single wavelength. Preferably, the illumination device for photoreducing blood sugar provided in this embodiment can use a single-wavelength red light LED, or can use multiple single-wavelength red light LEDs.
[0057] See also Figure 3 Preferably, the red light LED used in the illumination device for light-lowering blood sugar in this embodiment can also emit wide-band red light, and the band range is in the band of 600nm to 710nm. Preferably, the red light LED in this embodiment emits wide-band light. Preferably, the light emission band of the red light LED can also be 600-710nm, 640-660nm and 660-680nm.
[0058] Preferably, the lighting device provided in this embodiment can reduce blood sugar on the basis that, through light waves of a specific wavelength, entering from the visual window, it can directly activate photosensitive retinal ganglion cells ipRGCs (special photoreceptor cells), transmit signals through the optic nerve to a series of nerve nuclei in the hypothalamus and medulla oblongata, and finally act on the peripheral brown adipose tissue BAT through the sympathetic nerves, which can affect the metabolism of blood sugar. In addition, the red light emitted by the lighting device can not only increase the proportion of red light in the lighting light perceived by the human eye by emitting red light, but also reduce the proportion of blue light in the lighting light perceived by the human eye, thereby achieving the anti-blue light effect.
[0059] Preferably, the lighting device can make the human eye perceive red light, inhibit the heat production capacity of brown adipose tissue through the ipRGC-SON-PVN-NTS neural circuit, improve the metabolic function of human blood sugar, and reduce blood sugar. In addition, the red light emitted by the light-lowering blood sugar lighting device can also improve retinopathy caused by high blood sugar after entering the human eye.
[0060] Example 4
[0061] This embodiment is a further improvement on embodiment 3. Figure 4 , the lighting device in this embodiment can be a desk lamp. Figure 5 The lighting source 110 used in the desk lamp may be a lighting panel 111. The lighting panel 111 is used to emit lighting light. Figure 5 A plurality of LEDs 112 are disposed on one side of the lighting board 111. The LEDs 112 include red LEDs and white LEDs; the red LEDs have a light emission wavelength of 600 nm to 720 nm. The power module 120 is used to supply power to the plurality of LEDs 112 disposed on the lighting board 111. The processing unit 130 is used to adjust the light emission mode of the lighting board 111 by controlling the current output parameters of the power module 120.
[0062] Preferably, the red light LED used in the light-lowering blood sugar lighting device (desk lamp) in this embodiment can have a light-emitting band of 600-710nm. It is used to test 8 high-glycemic personnel. The test content is 3 hours after dinner every day, starting from 9:30 pm, the light-lowering blood sugar lighting device is used to irradiate for 30 minutes, and the blood sugar changes of the test personnel are recorded. Among them, the light-emitting mode of the light-lowering blood sugar lighting device is the third light-emitting mode; the indoor ambient light floor illumination is 70-80lim; the glasses are facing the lighting source 110, the distance is 50-60 cm; the test personnel take hypoglycemic drugs once after breakfast every day; the test results are shown in Table 2, and the blood sugar values in the table are all fingertip blood test data, unit: mmol / L.
[0063] The test results are shown in Table 1.
[0064] Table 1:
[0065]
[0066] Preferably, the red light LED used in the light-lowering blood sugar lighting device (desk lamp) in this embodiment can have a light emission band of 640-660nm. It is used to test 9 people with high blood sugar. The test content is 3 hours after dinner every day, starting from 9:30 pm, the light-lowering blood sugar lighting device is used to irradiate for 30 minutes, and the blood sugar changes of the test persons are recorded, wherein the light-lowering blood sugar lighting device is in the third light-emitting mode; the indoor ambient light floor illumination is 70-80lim; the glasses are facing the lighting source 110, the distance is 50-60 cm; the test person takes hypoglycemic medicine once a day after breakfast; the test results are shown in Table 2, and the blood sugar values in the table are all fingertip blood test data, unit: mmol / L.
[0067] Table 2:
[0068]
[0069] Preferably, the red light LED used in the light-lowering blood sugar lighting device (desk lamp) in this embodiment can have a light-emitting band of 660-680nm. It is used to test 9 people with high blood sugar. The test content is that 3 hours after dinner every day, the light-lowering blood sugar lighting device is used to irradiate for 30 minutes from 9:30 pm, and the blood sugar changes of the test persons are recorded. Among them, the light-emitting mode of the light-lowering blood sugar lighting device is the third light-emitting mode; the indoor ambient light floor illumination is 70-80lim; the glasses are facing the lighting source 110, and the distance is 50-60 cm; the test person takes hypoglycemic medicine once after breakfast every day; the test results are shown in Table 2, and the blood sugar values in the table are all fingertip blood test data, unit: mmol / L.
[0070] The test results are shown in Table 3.
[0071] Table 3:
[0072]
[0073] Preferably, the red light LED used in the light-lowering blood sugar lighting device (desk lamp) in this embodiment can have a light emission wavelength of 620nm. It is used to test 8 high blood sugar people. The test content is 3 hours after dinner every day, starting from 9:30 pm, the light-lowering blood sugar lighting device is used to irradiate for 30 minutes, and the blood sugar changes of the test persons are recorded, wherein the light-lowering blood sugar lighting device is in the third light-emitting mode; the indoor ambient light floor illumination is 70-80lim; the glasses are facing the lighting source 110, the distance is 50-60 cm; the test person takes hypoglycemic medicine once a day after breakfast; the test results are shown in Table 2, and the blood sugar values in the table are all fingertip blood test data, unit: mmol / L.
[0074] The test results are shown in Table 4.
[0075] Table 4:
[0076]
[0077] Preferably, the red light LED used in the light-lowering blood sugar lighting device (desk lamp) in this embodiment can have a light emission wavelength of 710nm. It is used to test 9 people with high blood sugar. The test content is 3 hours after dinner every day, starting from 9:30 pm, the light-lowering blood sugar lighting device is used to irradiate for 30 minutes, and the blood sugar changes of the test persons are recorded, wherein the light-lowering blood sugar lighting device is in the third light-emitting mode; the indoor ambient light floor illumination is 70-80lim; the glasses are facing the lighting source 110, the distance is 50-60 cm; the test person takes hypoglycemic medicine once a day after breakfast; the test results are shown in Table 2, and the blood sugar values in the table are all fingertip blood test data, unit: mmol / L.
[0078] The test results are shown in Table 5.
[0079] Table 5:
[0080]
[0081] Preferably, the red light LED used in the light-lowering blood sugar lighting device (desk lamp) in this embodiment can have a light emission wavelength of 655nm. 17 hyperglycemic persons were tested using it. The test content was 3 hours after dinner every day, and the light-lowering blood sugar lighting device was used to irradiate for 30 minutes from 9:30 pm to record the blood sugar changes of the test persons. The light-emitting mode of the light-lowering blood sugar lighting device was the third light-emitting mode; the indoor ambient light floor illumination was 70-80lim; the glasses were facing the lighting source 110, at a distance of 50-60 cm; the test persons took hypoglycemic drugs once a day after breakfast; the test results are shown in Table 2, and the blood sugar values in the table are all fingertip blood test data, unit: mmol / L.
[0082] Table 6:
[0083]
[0084] According to the test data in Table 1, Table 2, Table 3, Table 4, Table 5 and Table 6, it can be known that the light-induced blood sugar-lowering lighting device (desk lamp) provided in this embodiment can effectively lower blood sugar.
[0085] Example 5
[0086] This embodiment is a further improvement on embodiment 3. Figure 6 , the lighting device in this embodiment can be a ceiling lamp for photoreducing blood sugar. Preferably, the ceiling lamp includes: an illumination light source 110, a power module 120 and a processing unit 130. The illumination light source 110 is used to emit illumination light. The illumination light source 110 may include a red light LED and a white light LED; the light emission wavelength of the red light LED is 600nm to 720nm. The power module 120 is used to power the illumination light source 110. The power module 120 is configured with two power supply outputs, the first power supply output is connected to the red light LED, and the second power supply output is connected to the white light LED. The processing unit 130 is used to adjust the light emission mode of the illumination light source 110. The processing unit 130 adjusts the light emission mode of the illumination light source 110 by controlling the current output parameters of the power module 120.
[0087] Preferably, the red light LED used in the light-lowering blood sugar lighting device (ceiling lamp) in this embodiment can have a light-emitting band of 600-710nm. It is used to test 8 people with high blood sugar. The test content is that 3 hours after dinner every day, the light-lowering blood sugar lighting device is used to irradiate for 30 minutes from 9:30 pm, and the blood sugar changes of the test persons are recorded. Among them, the light-emitting mode of the light-lowering blood sugar lighting device is the third light-emitting mode; the indoor ambient light floor illumination is 70-80lim; the glasses are facing the lighting source 110, and the distance is 50-60 cm; the test person takes hypoglycemic medicine once a day after breakfast; the test results are shown in Table 7, and the blood sugar values in the table are all fingertip blood test data, unit: mmol / L.
[0088] The test results are shown in Table 7.
[0089] Table 7:
[0090]
[0091] Preferably, the red light LED used in the light-lowering blood sugar lighting device (ceiling lamp) in this embodiment can have a light-emitting band of 640-660nm. It was used to test 9 people with high blood sugar. The test content was 3 hours after dinner every day, and the light-lowering blood sugar lighting device was used to irradiate for 30 minutes from 9:30 pm to record the blood sugar changes of the test persons. The light-emitting mode of the light-lowering blood sugar lighting device was the third light-emitting mode; the indoor ambient light floor illumination was 70-80lim; the glasses were facing the lighting source 110, with a distance of 50-60 cm; the test persons took hypoglycemic drugs once a day after breakfast; the test results are shown in Table 8, and the blood sugar values in the table are all fingertip blood test data, unit: mmol / L.
[0092] Table 8:
[0093]
[0094] Preferably, the red light LED used in the light-lowering blood sugar lighting device (ceiling lamp) in this embodiment can have a light-emitting band of 660-680nm. It is used to test 9 people with high blood sugar. The test content is that 3 hours after dinner every day, the light-lowering blood sugar lighting device is used to irradiate for 30 minutes from 9:30 pm, and the blood sugar changes of the test persons are recorded. Among them, the light-emitting mode of the light-lowering blood sugar lighting device is the third light-emitting mode; the indoor ambient light floor illumination is 70-80lim; the glasses are facing the lighting source 110, the distance is 50-60 cm; the test person takes hypoglycemic medicine once after breakfast every day; the test results are shown in Table 9, and the blood sugar values in the table are all fingertip blood test data, unit: mmol / L.
[0095] Table 9:
[0096]
[0097] Preferably, the red light LED used in the light-lowering blood sugar lighting device (ceiling lamp) in this embodiment can have a light emission wavelength of 620nm. It is used to test 8 people with high blood sugar. The test content is 3 hours after dinner every day, starting from 9:30 pm, the light-lowering blood sugar lighting device is used to irradiate for 30 minutes, and the blood sugar changes of the test persons are recorded. Among them, the light-emitting mode of the light-lowering blood sugar lighting device is the third light-emitting mode; the indoor ambient light floor illumination is 70-80lim; the glasses are facing the lighting source 110, the distance is 50-60 cm; the test person takes hypoglycemic drugs once a day after breakfast; the test results are shown in Table 10, and the blood sugar values in the table are all fingertip blood test data, unit: mmol / L.
[0098] Table 10:
[0099]
[0100] Preferably, the red light LED used in the light-lowering blood sugar lighting device (ceiling lamp) in this embodiment can have a light emission wavelength of 710nm. It was used to test 9 people with high blood sugar. The test content was 3 hours after dinner every day, starting from 9:30 pm, the light-lowering blood sugar lighting device was used to irradiate for 30 minutes, and the blood sugar changes of the test persons were recorded. Among them, the light-lowering blood sugar lighting device was in the third light-emitting mode; the indoor ambient light floor illumination was 70-80lim; the glasses were facing the lighting source 110, with a distance of 50-60 cm; the test persons took hypoglycemic drugs once a day after breakfast; the test results are shown in Table 11, and the blood sugar values in the table are all fingertip blood test data, unit: mmol / L.
[0101] Table 11:
[0102]
[0103] Preferably, the red light LED used in the light-lowering blood sugar lighting device (ceiling lamp) in this embodiment can have a light emission wavelength of 655nm. 17 people with high blood sugar were tested using it. The test content was 3 hours after dinner every day, starting from 9:30 pm, the light-lowering blood sugar lighting device was used to irradiate for 30 minutes, and the blood sugar changes of the test persons were recorded. The light-emitting mode of the light-lowering blood sugar lighting device was the third light-emitting mode; the indoor ambient light floor illumination was 70-80lim; the glasses were facing the lighting source 110, at a distance of 50-60 cm; the test persons took hypoglycemic drugs once a day after breakfast; the test results are shown in Table 12, and the blood sugar values in the table are all fingertip blood test data, unit: mmol / L.
[0104] Table 12:
[0105]
[0106] According to the test data in Table 7, Table 8, Table 9, Table 10, Table 11 and Table 12, it can be known that the light-induced blood sugar-lowering lighting device (ceiling lamp) provided in this embodiment can effectively lower blood sugar.
[0107] Example 6
[0108] This embodiment is a further improvement on embodiment 3. Figure 7 , the lighting device in this embodiment can be a floor lamp. The floor lamp includes an illumination light source 110, a power module 120 and a processing unit 130. The illumination light source 110 is used to emit illumination light. The illumination light source 110 is provided with a plurality of LEDs 112, and the illumination light source 110 is connected to a support 113. The LEDs 112 include red light LEDs and white light LEDs. The emission wavelength of the red light LED is 600nm to 720nm. The power module 120 is used to supply power to the plurality of LEDs 112 provided in the illumination light source 110. The processing unit 130 is used to adjust the light emission mode of the illumination light source 110 by controlling the current output parameters of the power module 120.
[0109] Preferably, the red light LED used in the light-lowering blood sugar lighting device (floor lamp) in this embodiment can have a light emission band of 600-710nm. It is used to test 8 people with high blood sugar. The test content is 3 hours after dinner every day, starting from 9:30 pm, the light-lowering blood sugar lighting device is used to irradiate for 30 minutes, and the blood sugar changes of the test persons are recorded, wherein the light-lowering blood sugar lighting device is in the third light-emitting mode; the indoor ambient light floor illumination is 70-80lim; the glasses are facing the lighting source 110, the distance is 50-60 cm; the test person takes hypoglycemic medicine once a day after breakfast; the test results are shown in Table 13, and the blood sugar values in the table are all fingertip blood test data, unit: mmol / L.
[0110] Table 13:
[0111]
[0112] Preferably, the red light LED used in the light-lowering blood sugar lighting device (floor lamp) in this embodiment can have a light-emitting band of 640-660nm. It is used to test 9 people with high blood sugar. The test content is that 3 hours after dinner every day, the light-lowering blood sugar lighting device is used to irradiate for 30 minutes from 9:30 pm, and the blood sugar changes of the test persons are recorded. Among them, the light-emitting mode of the light-lowering blood sugar lighting device is the third light-emitting mode; the indoor ambient light floor illumination is 70-80lim; the glasses are facing the lighting source 110, the distance is 50-60 cm; the test person takes hypoglycemic medicine once a day after breakfast; the test results are shown in Table 14, and the blood sugar values in the table are all fingertip blood test data, unit: mmol / L.
[0113] Table 14:
[0114]
[0115] Preferably, the red light LED used in the light-lowering blood sugar lighting device (floor lamp) in this embodiment can have a light-emitting band of 660-680nm. It was used to test 9 people with high blood sugar. The test content was 3 hours after dinner every day, and the light-lowering blood sugar lighting device was used to irradiate for 30 minutes from 9:30 pm to record the blood sugar changes of the test persons. The light-emitting mode of the light-lowering blood sugar lighting device was the third light-emitting mode; the indoor ambient light floor illumination was 70-80lim; the glasses were facing the lighting source 110, with a distance of 50-60 cm; the test persons took hypoglycemic drugs once a day after breakfast; the test results are shown in Table 15, and the blood sugar values in the table are all fingertip blood test data, unit: mmol / L.
[0116] Table 15:
[0117]
[0118] Preferably, the red light LED used in the light-lowering blood sugar lighting device (floor lamp) in this embodiment can have a light emission wavelength of 620nm. It is used to test 8 people with high blood sugar. The test content is 3 hours after dinner every day, starting from 9:30 pm, the light-lowering blood sugar lighting device is used to irradiate for 30 minutes, and the blood sugar changes of the test persons are recorded, wherein the light-lowering blood sugar lighting device is in the third light-emitting mode; the indoor ambient light floor illumination is 70-80lim; the glasses are facing the lighting source 110, the distance is 50-60 cm; the test person takes hypoglycemic drugs once a day after breakfast; the test results are shown in Table 16, and the blood sugar values in the table are all fingertip blood test data, unit: mmol / L.
[0119] Table 16:
[0120]
[0121] Preferably, the red light LED used in the light-lowering blood sugar lighting device (floor lamp) in this embodiment can have a light emission wavelength of 710nm. It was used to test 9 people with high blood sugar. The test content was 3 hours after dinner every day, and the light-lowering blood sugar lighting device was used to irradiate for 30 minutes from 9:30 pm to record the blood sugar changes of the test persons. The light-emitting mode of the light-lowering blood sugar lighting device was the third light-emitting mode; the indoor ambient light floor illumination was 70-80lim; the glasses were facing the lighting source 110, with a distance of 50-60 cm; the test persons took hypoglycemic drugs once a day after breakfast; the test results are shown in Table 17, and the blood sugar values in the table are all fingertip blood test data, unit: mmol / L.
[0122] Table 17:
[0123]
[0124] Preferably, the red light LED used in the light-lowering blood sugar lighting device (floor lamp) in this embodiment can have a light emission wavelength of 655nm. 17 people with high blood sugar were tested using it. The test content was 3 hours after dinner every day, starting from 9:30 pm, using the light-lowering blood sugar lighting device to irradiate for 30 minutes, and recording the blood sugar changes of the test persons, wherein the light-lowering blood sugar lighting device was in the third light-emitting mode; the indoor ambient light floor illumination was 70-80lim; the glasses were facing the lighting source 110, at a distance of 50-60 cm; the test persons took hypoglycemic drugs once a day after breakfast; the test results are shown in Table 18, and the blood sugar values in the table are all fingertip blood test data, unit: mmol / L.
[0125] Table 18:
[0126]
[0127] According to the test data in Table 13, Table 14, Table 15, Table 16, Table 17 and Table 18, it can be known that the light-induced blood sugar-lowering lighting device (floor lamp) provided in this embodiment can effectively lower blood sugar.
[0128] Example 7
[0129] This embodiment provides a lighting device for light-lowering blood sugar, and this embodiment is a further improvement of embodiments 1, 2, and 3, and the repeated contents are not repeated here. In this embodiment, the processing unit 130 can switch the light-emitting mode of the lighting device for light-lowering blood sugar according to the instructions sent by the user. The instructions sent by the user can be sent to the processing unit 130 by sending an electrical signal through a key switch, or by establishing a wireless communication connection with the processing unit 130 through a wireless device such as a remote control or a mobile phone, and then sending the instructions.
[0130] Preferably, the continuous lighting duration of the red LED is set to 30 minutes. When the lighting device continuously lights up in the second lighting mode or the third lighting mode for 30 minutes, the processing unit 130 controls the power module 120 to cut off the first power supply output, so that the red LED is turned off.
[0131] Preferably, when the lighting device continues to emit light in the second light-emitting mode for 30 minutes, the processing unit 130 controls the power supply module 120 to cut off the first power supply output and turn on the second power supply output, so that the red light LED is turned off and the white light LED is illuminated, and the lighting device switches from the second light-emitting mode to the first light-emitting mode.
[0132] Preferably, when the lighting device continues to emit light in the third light-emitting mode for 30 minutes, the processing unit 130 controls the power supply module 120 to cut off the first power supply output and keep the second power supply output turned on, so that the red light LED is turned off and the white light LED is illuminated, and the lighting device switches from the third light-emitting mode to the first light-emitting mode.
[0133] Example 8
[0134] The present embodiment provides a lighting system for photoreduction of blood sugar. The lighting system of the present embodiment includes a lighting device and a control device as described in any one of Embodiments 1 to 7. The control device is used to switch the lighting mode of the lighting device. Preferably, the control device can be a key switch or a wireless device such as a remote control or a mobile phone. The user can send an electrical signal to the processing unit 130 through a key switch to switch the lighting mode of the lighting device, or establish a wireless communication connection with the processing unit 130 through a wireless device such as a remote control or a mobile phone, and then send a command to switch the lighting mode of the lighting device.
[0135] Preferably, the continuous lighting time of the red LED does not exceed 30 minutes.
[0136] Example 9
[0137] This embodiment provides a method for using a lighting system for photoreducing blood sugar. The lighting system involved in this embodiment may be the lighting system in Example 8. The method for using provided in this embodiment includes:
[0138] The lighting mode of the lighting device is switched by using a control device; wherein the continuous lighting duration of the red light LED is set to 30 minutes. When the lighting device continuously emits light in the second lighting mode for 30 minutes, the lighting device switches from the second lighting mode to the first lighting mode. When the lighting device continuously emits light in the third lighting mode for 30 minutes, the lighting device switches from the third lighting mode to the first lighting mode.
[0139] Preferably, the continuous lighting duration of the red LED is set to 30 minutes. When the lighting device continuously lights up in the second lighting mode or the third lighting mode for 30 minutes, the processing unit controls the power supply module to cut off the first power supply output, so that the red LED is turned off.
[0140] Preferably, when the lighting device continues to emit light in the second light-emitting mode for 30 minutes, the processing unit controls the power supply module to cut off the first power supply output and turn on the second power supply output, so that the red light LED is turned off and the white light LED is illuminated, and the lighting device switches from the second light-emitting mode to the first light-emitting mode.
[0141] Preferably, when the lighting device continues to emit light in the third light-emitting mode for 30 minutes, the processing unit controls the power supply module to cut off the first power supply output and keep the second power supply output turned on, so that the red light LED is turned off and the white light LED is illuminated, and the lighting device switches from the third light-emitting mode to the first light-emitting mode.
[0142] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions and improvements made within the spirit and principles of the present invention should be included in the protection scope of the present invention.
Claims
1. A lighting device for reducing blood sugar by light, characterized in that: include: An illumination light source (110) for emitting illumination light, wherein the illumination light source (110) comprises at least a red light LED and a white light LED; the emission wavelength of the red light LED is 600 nm to 720 nm; A power module (120) is used to supply power to the lighting light source (110), wherein the power module (120) is configured with two power outputs, a first power output connected to a red light LED, and a second power output connected to a white light LED; A processing unit (130) for adjusting the light emission mode of the illumination light source (110); The processing unit (130) controls the current output parameters of the power module (120) to adjust the light emission mode of the illumination light source (110).
2. The light-induced blood sugar-lowering lighting device according to claim 1, characterized in that: The lighting method of the illumination light source (110) includes: A first light emitting mode, in which the red light LED in the illumination light source (110) does not emit light, and the white light LED emits light; A second light emitting mode, in which the red light LED in the illumination light source (110) emits light and the white light LED does not emit light; In a third light emitting mode, the red light LED in the illumination light source (110) emits light and the white light LED emits light.
3. The light-induced blood sugar-lowering lighting device according to claim 2, characterized in that: The processing unit (130) controls the first power output of the power module (120) to be cut off and the second power output to be turned on, so that the lighting light source (110) enters the first light-emitting mode; The processing unit (130) controls the first power output of the power module (120) to be turned on and the second power output to be turned off, so that the lighting light source (110) enters the second light-emitting mode; The processing unit (130) controls the first power output of the power module (120) to be turned on, and the second power output to be turned on, so that the lighting light source (110) enters the third light-emitting mode.
4. The light-induced blood sugar-lowering lighting device according to claim 2, characterized in that: In the second light-emitting mode, the radiation intensity of the red light perceived by human eyes is less than the preset radiation intensity; Wherein, the preset radiation intensity is 700mW.
5. The light-induced blood sugar-lowering lighting device according to claim 2, characterized in that: In the third light emitting mode, the red light power intensity of the illumination light source (110) is greater than the blue light power intensity, The optical power intensity of the red light=the optical power intensity of the red light LED+the optical power intensity of the red light in the white light LED, and the optical power intensity of the blue light=the optical power intensity of the blue light in the white light LED.
6. The lighting device for reducing blood sugar by light according to claim 2, characterized in that: In the third light emitting mode, the ratio of the lighting power of the red light LED to the lighting power of the white light LED is greater than or equal to 30%.
7. The lighting device for reducing blood sugar by light according to claim 2, characterized in that: In the third light emitting mode, the illumination of the red light LED is greater than the illumination of the white light LED.
8. The lighting device for reducing blood sugar by light according to claim 2, characterized in that: In the third light-emitting mode, the illuminance of the red LED is greater than a second preset illuminance, wherein the preset illuminance is greater than or equal to 1000 lx.
9. The lighting device for reducing blood sugar by light according to claim 1, characterized in that: The light emission wavelength of the red light LED is at least one wavelength between 620nm and 720nm.
10. The lighting device for photoreducing blood sugar according to claim 9, characterized in that: The red light LED is a wide-spectrum light-emitting LED, and its spectrum covers a range of 600nm to 710nm.
11. A light-induced blood sugar-lowering desk lamp, characterized in that: include: An illumination board (111) for emitting illumination light, wherein a plurality of LEDs (112) are arranged on a surface of one side of the illumination board (111), and the LEDs (112) include red light LEDs and white light LEDs; the emission wavelength of the red light LEDs is 600 nm to 720 nm; A power module (120) for supplying power to a plurality of LEDs (112) arranged on the lighting panel (111); The processing unit (130) is used to adjust the light-emitting mode of the lighting panel (111) by controlling the current output parameters of the power module (120).
12. A ceiling lamp for reducing blood sugar by light, characterized in that: include: An illumination light source (110) for emitting illumination light; wherein the illumination light source (110) comprises at least a red light LED and a white light LED; the emission wavelength of the red light LED is 600 nm to 720 nm; A power module (120) is used to supply power to the lighting light source (110), wherein the power module (120) is configured with two power outputs, a first power output connected to a red light LED, and a second power output connected to a white light LED; A processing unit (130) for adjusting the light emission mode of the illumination light source (110); The processing unit (130) controls the current output parameters of the power module (120) to adjust the light emission mode of the illumination light source (110).
13. A floor lamp for reducing blood sugar by light, characterized in that: include: An illumination light source (110) for emitting illumination light; wherein the illumination light source (110) is provided with a plurality of LEDs (112), and the illumination light source (110) is connected to a support (113); the LEDs (112) include red light LEDs and white light LEDs; the emission wavelength of the red light LEDs is 600 nm to 720 nm; A power module (120) for supplying power to a plurality of LEDs (112) provided in the illumination light source (110); The processing unit (130) is used to adjust the light-emitting mode of the illumination light source (110) by controlling the current output parameters of the power module (120).
14. A lighting system for reducing blood sugar by light, characterized in that: comprising the lighting device and control device as claimed in any one of claims 1 to 10, The control device is used to switch the light-emitting mode of the lighting device; Among them, the continuous lighting time of the red light LED does not exceed 30 minutes.
15. A method for using a lighting system for reducing blood sugar by light, characterized in that: in, The lighting system as claimed in claim 14; The usage method includes at least: Using a control device to switch the lighting mode of the lighting device; Among them, the continuous lighting time of the red LED is set to 30 minutes; When the lighting device continues to emit light in the second light-emitting mode for 30 minutes, the lighting device switches from the second light-emitting mode to the first light-emitting mode; When the lighting device continues to emit light in the third light-emitting mode for 30 minutes, the lighting device switches from the third light-emitting mode to the first light-emitting mode.
Citation Information
Patent Citations
Lamp
CN112413455A
Illumination method and illumination device for relieving eyestrain and application
CN116928626A
Eye protection lighting method, lighting device and application
CN117346106A
Light source module and illuminating device
US20180335189A1
Cited By
Red-light fluorescent composition, red-light fluorescent film and LED (light-emitting diode) light source for reducing blood sugar by light
CN119955515A
